Skip to content

The Prescriptive Validity of a Novel Fall Risk Clinical Prediction Rule for People With COPD

The Prescriptive Validity of a Novel Fall Risk Clinical Prediction Rule for People With COPD

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05173532
Enrollment
88
Registered
2021-12-30
Start date
2021-02-10
Completion date
2022-12-31
Last updated
2022-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Keywords

Balance, Falls, Fall Risk, Aerobic Exercise, Strength Training, Fall Prevention, Stretching Exercise, Breathing Exercise, Randomized Controlled Trial, Clinical Prediction Rule, Minimal Clinically Important Difference

Brief summary

This study has 3 objectives: (1) demonstrate the effectiveness of balance training for people with COPD, (2) determine which patients with COPD respond best to balance training, and (3) calculate clinically meaningful changes in balance for patients with COPD.

Detailed description

After receiving a detailed explanation of the study, including its risks and benefits, and providing informed consent, patients will be screened for eligibility criteria during a single 75-minute evaluation for participation in a physical therapy based pulmonary rehabilitation program. Those meeting eligibility criteria will be randomly assigned in blocks of four (by clinical site) in a single-blind manner (patients) in a 1:1 ratio to either balance training or a breathing and stretching exercise program. Both groups will receive respiratory muscle stretch exercises, aerobic exercise, strength training, and fall prevention education. The intervention phase will last 8 weeks, with patients being seen 3 times per week for 75 minute sessions supervised by a physical therapist or physical therapist assistant.

Interventions

OTHERBalance Training

static and dynamic balance and gait stability exercises

OTHERBreathing and Stretching Exercises

static stretching while performing diaphragmatic breathing

Sponsors

Texas Woman's University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

The patients will be blinded to their group assignment. At the time of their group assignment, they will be told that they are in either group A (which is actually the experimental group receiving balance training) or B (which is actually the active control group receiving the breathing and stretching exercise program), and that both groups may lead to better balance, neither are expected to worsen balance, and it is uncertain which one is more effective at improving balance. After their study participation, patients will guess which group they were in, then told if they guessed correctly.

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* having reported a fall in the past 5 years, or a near fall in the past year, or a score ≥ 9 on the Short Version of the Falls Efficacy Scale - International Version * age ≥ 60 years * both sexes * spirometrically-confirmed COPD of all disease severity stages * being independently ambulatory with or without a gait aid * medical clearance by a physician to participate in pulmonary rehabilitation * provision of informed consent.

Exclusion criteria

* having suffered a recent, severe COPD exacerbation (recent is 30 days or less prior to the study baseline) * participation in a formal exercise program in the three months prior to the study baseline * an inability by the patient to complete all study testing due to physical, psychological, communication-barrier, or other unanticipated reasons.

Design outcomes

Primary

MeasureTime frameDescription
Change in Brief Balance Evaluation Systems Test total score baseline to 4 weeks4 weeks8-item balance test battery, each item rated from 0-3 then summed for total score, items #3 and #4 are tested on both the right and left side. (#1) HIP/TRUNK LATERAL STRENGTH, (#2) FUNCTIONAL REACH FORWARD, (#3) SINGLE-LEG STANCE, (#4) COMPENSATORY STEPPING CORRECTION- LATERAL, (#5) STAND ON FOAM, EYES CLOSED: (3) 30s stable (2) 30s unstable (1) \< 30s (0) Unable, (#6) TIMED GET UP & GO
Change in Brief Balance Evaluation Systems Test total score baseline to 8 weeks8 weeks8-item balance test battery, each item rated from 0-3, then summed for total score, items #3 and #4 are tested on both the right and left side. (#1) HIP/TRUNK LATERAL STRENGTH, (#2) FUNCTIONAL REACH FORWARD, (#3) SINGLE-LEG STANCE, (#4) COMPENSATORY STEPPING CORRECTION- LATERAL, (#5) STAND ON FOAM, EYES CLOSED: (3) 30s stable (2) 30s unstable (1) \< 30s (0) Unable, (#6) TIMED GET UP & GO

Secondary

MeasureTime frameDescription
Global Rating of Change in Balance after 4 weeks4 weeks11-point self-report outcome rating balance improvement(+) or decline(-). Ratings: (+/-5)=very large, (+/-4)=large, (+/-3)=medium, (+/-2)=small, (+/-1)=very small, (0)=none
Global Rating of Change in Balance after 8 weeks8 weeks11-point self-report outcome rating balance improvement(+) or decline(-). Ratings: (+/-5)=very large, (+/-4)=large, (+/-3)=medium, (+/-2)=small, (+/-1)=very small, (0)=none

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026